financetom
Business
financetom
/
Business
/
Confluent's 2026 Growth Profile Seen Improving, Morgan Stanley Says
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Confluent's 2026 Growth Profile Seen Improving, Morgan Stanley Says
Oct 28, 2025 8:28 AM

11:05 AM EDT, 10/28/2025 (MT Newswires) -- Confluent (CFLT) is heading into 2026 with a more favorable outlook than a year earlier, supported by "encouraging" Q3 trends, Morgan Stanley said Tuesday in a report.

The firm cited improving consensus expectations for Confluent Cloud and subscription revenue growth. If Q4 trends mirror Q3, Morgan Stanley sees potential for year-end growth rates to reach 22% for Confluent Cloud and 20% for subscription revenue.

Confluent's Q4 subscription revenue guidance of $295.5 million to $296.5 million came in 1% ahead of consensus, the report said. Morgan Stanley is modeling Confluent Cloud revenue at $165 million in the quarter, up 20% from a year earlier.

On Monday, Confluent reported Q3 adjusted earnings and revenue that beat analyst estimates. Morgan Stanley cited stronger month-over-month consumption trends and a pickup in bookings, with remaining performance obligations growing 27% from a year earlier.

The firm raised its price target on Confluent stock to $27 from $25 and maintained its equal weight rating, "but look to turn more positive on signs that improved execution can support durable stabilization, and eventual acceleration, in Cloud growth."

Confluent shares rose 10% in Tuesday trading.

Price: 24.29, Change: +2.21, Percent Change: +10.01

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Sector Update: Health Care
Sector Update: Health Care
Nov 9, 2024
01:33 PM EST, 11/08/2024 (MT Newswires) -- Health care stocks were higher Friday afternoon, with the NYSE Health Care Index rising 0.8% and the Health Care Select Sector SPDR Fund (XLV) adding 1%. The iShares Biotechnology ETF (IBB) rose 0.3%. In corporate news, Astrana Health ( ASTH ) said Friday it agreed to buy certain businesses and assets of Prospect...
Sector Update: Health Care Stocks Rise in Afternoon Trading
Sector Update: Health Care Stocks Rise in Afternoon Trading
Nov 9, 2024
01:58 PM EST, 11/08/2024 (MT Newswires) -- Health care stocks were higher Friday afternoon, with the NYSE Health Care Index rising 0.9% and the Health Care Select Sector SPDR Fund (XLV) adding 1.1%. The iShares Biotechnology ETF (IBB) rose 0.5%. In corporate news, Astrana Health ( ASTH ) said Friday it agreed to buy certain businesses and assets of Prospect...
US agency raises concerns about Tesla Full Self-Driving social media posts
US agency raises concerns about Tesla Full Self-Driving social media posts
Nov 9, 2024
WASHINGTON (Reuters) - The National Highway Traffic Safety Administration raised concerns about Tesla social media posts that suggested its Full Self-Driving software can be used as a robotaxi and do not need driver attention. NHTSA in October opened an investigation into 2.4 million Tesla vehicles with FSD software after four reported collisions, including a 2023 fatal crash. In a May...
Meta's Zuckerberg not liable in lawsuits over social media harm to children
Meta's Zuckerberg not liable in lawsuits over social media harm to children
Nov 9, 2024
(Reuters) - A federal judge said Meta Platforms ( META ) CEO Mark Zuckerberg is not personally liable in 25 lawsuits accusing his company of addicting children to social media. U.S. District Judge Yvonne Gonzalez Rogers in Oakland, California rejected accusations on Thursday that Zuckerberg directed Meta's efforts to conceal from children the serious mental health risks of using Facebook...
Copyright 2023-2026 - www.financetom.com All Rights Reserved